Sarah Rajabi

Sarah Rajabi

Auto-generated profile, based on publicly available information

Sarah Rajabi

Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2017 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Open access
PDF file
SRSarah Rajabi
Sarah Rajabi
SFSasan Jalili Firoozinezhad
Sasan Jalili Firoozinezhad
MAMohammad Kazemi Ashtiani
Mohammad Kazemi Ashtiani
GCGilles Le Carrou
Gilles Le Carrou
STShahragim Tajbakhsh
Shahragim Tajbakhsh
HBHossein Baharvand
Hossein Baharvand
The availability of three-dimensional bioactive scaffolds with enhanced angiogenic capacity that have the capability to recruit tissue specific resident progenitors is of great importance for the regeneration of impaired skeletal muscle. Here, we have investigated whether introduction of chemoattractant factors to tissue specific extracellular matrix promotes cellular behaviour in vitro as well as muscle progenitor recruitment and vascularization in vivo. We developed an interconnective macroporous sponge from decellularized skeletal muscle with maintained biochemical traits of the intact muscle. SDF-1α, a potent cell homing factor involved in muscle repair, was physically adsorbed or chemically immobilized in these muscle-derived sponges. The immobilized sponges showed significantly higher SDF-1α conjugation efficiency along with improved metabolism and infiltration of muscle-derived stem cells in vitro, and thus generated uniform cellular constructs. In vivo, femoral muscle implantation in rats revealed a negligible immune response in all scaffold groups. We observed enhanced engraftment, neovascularization, and infiltration of CXCR4+ cells in the immobilized-SDF-1α sponge compared with nonimmobilized controls. Although Pax7+ cells identified adjacent to the immobilized-SDF-1α implantation site, other factors appear to be necessary for efficient penetration of Pax7+ cells into the sponge. These findings suggest that immobilization of cell homing factors via chemical mediators can result in recruitment of cells to the microenvironment with subsequent improvement in angiogenesis.

1 January 2022
Verified
Journal Article
Open access
MPMohamad Pezeshki-Modaress
Mohamad Pezeshki-Modaress
MAMohadeseh Akbarzadeh
Mohadeseh Akbarzadeh
DEDariush Ebrahimibagha
Dariush Ebrahimibagha
MZMojgan Zandi
Mojgan Zandi
TGTayyeb Ghadimi
Tayyeb Ghadimi
SRSarah Rajabi
Sarah Rajabi
Poly(ε-caprolactone) (PCL) has considerable mechanical and biological properties that make it a good candidate for tissue engineering applications. PCL alongside proteins and polysaccharides, like gelatin (GEL) and chondroitin sulphate (CS), can be used to fabricate composite scaffolds that provide mechanical and biological requirements for skin tissue engineering scaffolds. The aim of this study was fabricating novel composite nanofibrous scaffold containing various ratios of GEL/CS and PCL using co-electrospinning process. In this experimental study, PCL mixed with a GEL/CS blend has limitations in miscibility and the lack of a common solvent. Here, we electrospun PCL and GEL/CS coincide separately on the same drum by using different nozzles to create composite nanofibrous scaffolds with different ratios (2:1, 1:1 and 1:2) of GEL to CS- PCL, and we mixed them at the micro/nanoscale. Morphology, porosity, phosphate-buffered saline (PBS) absorption, chemical structure, mechanical property and in vitro bioactivity of the prepared composite scaffolds were analysed. Scanning electron microscopy (SEM) images showed beadless nanofibres at all ratios of GEL to CS-PCL. The composite scaffolds (2:1, 1:1 and 1:2) had increased porosity compared to the PCL nanofibrous scaffolds, in addition to a significant increase in PBS absorption. The mechanical properties of the composite scaffolds were investigated under different conditions. The results demonstrated that all of the composite specimens had better strength when compared with the GEL/CS nanofibres. The increase in PCL ratio led to an increase in tensile strength of the nanofibres. Human dermal fibroblasts (HDF) were cultured on the fabricated composite scaffolds and evaluated by 3-(4,5-dimethylthiazol- 2-yl)-5-(3 carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) analysis and SEM. The results showed the bioactivity of these nanofibres and the potential for these scaffolds to be used for skin tissue engineering applications. The fabricated co-electrospun composite scaffolds had higher porosity and PBS absorption in comparison with the PCL nanofibrous scaffolds, in addition to significant improvements in mechanical properties under wet and dry conditions compared to the GEL/CS scaffold.

30 May 2023 in Biological Procedures Online
Verified
Journal Article
Open access
MEMorvarid Ebadi
Morvarid Ebadi
AMAmirfarhang Miresmaeili
Amirfarhang Miresmaeili
SRSarah Rajabi
Sarah Rajabi
SSShahrokh Shojaei
Shahrokh Shojaei
SFSareh Farhadi
Sareh Farhadi

1 March 2021
Verified
Journal Article
Open access
ZSZahra Shams
Zahra Shams
BABabak Akbari
Babak Akbari
SRSarah Rajabi
Sarah Rajabi
NANasser Aghdami
Nasser Aghdami
Functional cardiac tissue engineering holds promise as a candidate approach for myocardial infarction. Tissue engineering has emerged to generate functional tissue constructs and provide an alternative means to repair and regenerate damaged heart tissues. In this experimental study, we fabricated a composite polycaprolactone (PCL)/gelatine electrospun scaffold with aligned nanofibres. The electrospinning parameters and optimum proportion of the PCL/ gelatine were tested to design a scaffold with aligned and homogenized nanofibres. Using scanning electron microscopy (SEM) and mechanophysical testes, the PCL/gelatine composite scaffold with a ratio of 70:30 was selected. In order to simulate cardiac contraction, a developed mechanical loading device (MLD) was used to apply a mechanical stress with specific frequency and tensile rate to cardiac progenitor cells (CPCs) in the direction of the aligned nanofibres. Cell metabolic determination of CPCs was performed using real-time polymerase chain reaction(RT-PCR). Physicochemical and mechanical characterization showed that the PCL/gelatine composite scaffold with a ratio of 70:30 was the best sample. In vitro analysis showed that the scaffold supported active metabolism and proliferation of CPCs, and the generation of uniform cellular constructs after five days. Real-time PCR analysis revealed elevated expressions of the specific genes for synchronizing beating cells (MYH-6, TTN and CX-43) on the dynamic scaffolds compared to the control sample with a static culture system. Our study provides a robust platform for generation of synchronized beating cells on a nanofibre patch that can be used in cardiac tissue engineering applications in the near future.

30 September 2025 in International Journal of Basic Science in Medicine
Verified
Journal Article
Closed access
FGFatemeh Hosseini Ghaemi
Fatemeh Hosseini Ghaemi
AZArmin Nazemi Zadeh
Armin Nazemi Zadeh
FYFarshid Yekani
Farshid Yekani
MMMaryam Malekzadeh
Maryam Malekzadeh
MHMahdi Hesaraki
Mahdi Hesaraki
SRSarah Rajabi
Sarah Rajabi
For centuries, there has been ongoing effort to regenerate living organs using tissues or their cells. Organoid technology involves the three-dimensional (3D) culture of various cell types, derived from tissue explants, tumors, stem cells, or other progenitor cells, which self-organize under controlled conditions to mimic the structure and function of real organs. Two-dimensional (2D) culture is the most exploited in vitro method providing advantages in terms of reproducibility, high throughput and cost- effectiveness. Even so, 2D culture generally fails to mimic a tissue or organ that possesses a defined 3D structure along with complicated intercellular communication. In fact, these cells are cultured in an environment similar to the body’s extracellular matrix. These organoids differentiate into functional cell types, acquiring the complexity of an organ’s anatomy and physiology. This innovative technology has revolutionized research and medicine, offering a powerful alternative to animal models in preclinical studies. Organoids have shown great promise in various therapeutic and research applications, although they are not without limitations. Despite these challenges, their potential and necessity in advancing biomedical research are undeniable. This review aims to explore both the applications and the challenges associated with organoid technology.

12 October 2024
Verified
Preprint
Open access
PDF file
SRSarah Rajabi
Sarah Rajabi
The study titled "Metadichol Induces CD14 Glycoprotein Expression in Human Embryonic Stem Cells and Fibroblasts" addresses an interesting and relevant topic. The manuscript is generally well-organized, which is appreciated. However, before it can be...